BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 37692500)

  • 1. Signaling pathways governing the behaviors of leukemia stem cells.
    Azizidoost S; Nasrolahi A; Sheykhi-Sabzehpoush M; Anbiyaiee A; Khoshnam SE; Farzaneh M; Uddin S
    Genes Dis; 2024 Mar; 11(2):830-846. PubMed ID: 37692500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
    Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
    Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia?
    Belmonte M; Hoofd C; Weng AP; Giambra V
    Curr Oncol; 2016 Feb; 23(1):34-41. PubMed ID: 26966402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
    Horne GA; Copland M
    Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia.
    Barbosa K; Deshpande AJ
    Front Oncol; 2023; 13():1204895. PubMed ID: 37601659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.
    Ruan Y; Kim HN; Ogana H; Kim YM
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses.
    Láinez-González D; Alonso-Aguado AB; Alonso-Dominguez JM
    Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
    Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated Notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia.
    Kang YA; Pietras EM; Passegué E
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31886826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis.
    Li H; Liu L; Zhuang J; Liu C; Zhou C; Yang J; Gao C; Liu G; Sun C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e851. PubMed ID: 31373443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling pathways governing glioma cancer stem cells behavior.
    Nasrolahi A; Azizidoost S; Radoszkiewicz K; Najafi S; Ghaedrahmati F; Anbiyaee O; Khoshnam SE; Farzaneh M; Uddin S
    Cell Signal; 2023 Jan; 101():110493. PubMed ID: 36228964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell signaling pathways as molecular targets to eliminate AML stem cells.
    Rodrigues ACBDC; Costa RGA; Silva SLR; Dias IRSB; Dias RB; Bezerra DP
    Crit Rev Oncol Hematol; 2021 Apr; 160():103277. PubMed ID: 33716201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.
    Naef P; Radpour R; Jaeger-Ruckstuhl CA; Bodmer N; Baerlocher GM; Doehner H; Doehner K; Riether C; Ochsenbein AF
    Sci Signal; 2023 Aug; 16(800):eadd7705. PubMed ID: 37643244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells.
    Moradi F; Babashah S; Sadeghizadeh M; Jalili A; Hajifathali A; Roshandel H
    Iran J Basic Med Sci; 2019 Jun; 22(6):581-589. PubMed ID: 31231484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia.
    Bhattacharjee R; Ghosh S; Nath A; Basu A; Biswas O; Patil CR; Kundu CN
    Crit Rev Oncol Hematol; 2022 Sep; 177():103753. PubMed ID: 35803452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
    Dong F; Bai H; Wang X; Zhang S; Wang Z; Xie M; Zhang S; Wang J; Hao S; Cheng T; Ema H
    Blood Adv; 2019 Feb; 3(3):419-431. PubMed ID: 30733302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.
    Schürch C; Riether C; Matter MS; Tzankov A; Ochsenbein AF
    J Clin Invest; 2012 Feb; 122(2):624-38. PubMed ID: 22232214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.